Stock listing
Antengene Corporation Limited
Selected listing: A2QHCZ · LS · EUR · DE
Antengene Corporation Limited (Lang & Schwarz: A2QHCZ), Health Technology. Latest release Oct 3, 2026: Antengene to Present Latest Preclinical Results…
- Ticker
- Lang & Schwarz: A2QHCZ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Antengene Corporation Limited
The company focuses on developing innovative therapies for cancer treatment. Antengene is committed to advancing its research and development efforts to address unmet medical needs in oncology.
Latest news from Antengene Corporation Limited
Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026
October 2, 2026
Next Day Disclosure Return
October 2, 2026
Next Day Disclosure Return
September 30, 2026
Next Day Disclosure Return
September 29, 2026
2026 INTERIM REPORT
September 29, 2026
Research Antengene Corporation Limited
Antengene Corporation Limited company profile
View the public company page for Antengene Corporation Limited on 6ix.
Antengene Corporation Limited news
Read company news and market updates connected to Antengene Corporation Limited.
Antengene Corporation Limited investor events
Find investor webinars, events, and replay context for Antengene Corporation Limited.
Alternate listings
6996:HKEX
HK · HKD
Alternate listing for Antengene Corporation Limited; the primary context on this page is A2QHCZ:LS.
722:FWB
DE · EUR
Alternate listing for Antengene Corporation Limited; the primary context on this page is A2QHCZ:LS.
A2QHCZ:LSX
DE · EUR
Alternate listing for Antengene Corporation Limited; the primary context on this page is A2QHCZ:LS.
722:SWB
DE · EUR
Alternate listing for Antengene Corporation Limited; the primary context on this page is A2QHCZ:LS.
722:TRADEGATE
DE · EUR
Alternate listing for Antengene Corporation Limited; the primary context on this page is A2QHCZ:LS.